Skip to main navigation
Skip to search
Skip to main content

Pure University (For Demo Only) Home

Help & FAQ
- English
- 中文

Home
Profiles
Research units
Research output
Equipment
Datasets
Activities
Prizes
Impacts
Projects
Press/Media

Search by expertise, name or affiliation

Recommended Phase 2 Dose of Selinexor Plus Pomalidomide and Dexamethasone Effective for Relapsed/Refractory Multiple Myeloma

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2025 Pure University (For Demo Only), its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility

Report vulnerability